RITA Medical Systems Announces Fourth Quarter and Year-End Results Release and Conference Call Date MOUNTAIN VIEW, Calif., Jan. 15 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) today announced plans to release its financial results for the fourth quarter and fiscal year ended

RITA Medical Systems Names Darrin R. Uecker Chief Technology Officer; Experienced Medical Device Executive to Lead Company's Technology Strategy RITA Medical Systems Names Darrin R. Uecker Chief Technology Officer; Experienced Medical Device Executive to Lead Company's Technology Strategy MOUNTAIN

Six-Month and One-Year Data Reports 90% Success Rate for Minimally
Invasive Radiofrequency Ablation Procedure

Forty-Eight Percent Five-Year Survival Rate for Primary Liver Cancer Patients Treated With Minimally Invasive Procedure Reported at RSNA Annual Meeting

Medical Advisory Panel Review Finds Radiofrequency Ablation for the Treatment
of Unresectable Primary Liver Tumors Meets Evaluation Criteria

Study Concludes Radiofrequency Ablation Is Effective Local Treatment for Liver Cancer Patients With Cirrhosis and Small Lesions

Sales of $3.9 Million; Reduced Operating Expenses and Cash Burn Rate; Improved Bottom-Line Results

E-Z-EM Considers Spin-Off and IPO of AngioDynamics subsidiary E-Z-EM Considers Spin-Off and IPO of AngioDynamics subsidiary LAKE SUCCESS, N.Y., Tuesday, October 20, 2003 – E-Z-EM, Inc. (AMEX: EZM) announced today that it was considering a spin-off and initial public offering of its

Sales of $3.9 Million; Reduced Operating Expenses and Cash Burn Rate; Improved Bottom-Line Results

Verona University Medical School Study Reports Three-Year Survival Rates Comparable to Surgical Resection in the Journal of Hepato-Gastroenterology

AngioDynamics Announces Availability of the AquaLiner™ Hydrophilic Guidewire in the United States AngioDynamics Announces Availability of the AquaLiner™ Hydrophilic Guidewire in the United States Queensbury, NY; October 15, 2003 -- AngioDynamics, Inc., a wholly owned subsidiary of

RITA Medical Systems, Inc. Ranked 228th Fastest Growing Technology Company in North America on the 2003 Deloitte Technology Fast 500 RITA Medical Systems, Inc. Ranked 228th Fastest Growing Technology Company in North America on the 2003 Deloitte Technology Fast 500 MOUNTAIN VIEW, Calif., Oct.

RITA Medical Systems to Present at Rodman & Renshaw Techvest Healthcare Conference MOUNTAIN VIEW, Calif., Oct. 9 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) today announced that it is scheduled to make an investor presentation at the Rodman & Renshaw Techvest Healthcare

RITA Medical Systems Announces Date and Time for Third Quarter and Nine-Month Results Release and Conference Call RITA Medical Systems Announces Date and Time for Third Quarter and Nine-Month Results Release and Conference Call MOUNTAIN VIEW, Calif., Oct.

Experienced Marketing Executive to Focus on the Development of Integrated Marketing Communications Programs for Existing and New Markets

Proven Sales and Marketing Executive to Focus on International Sales Growth/Market Share

New StarBurst(TM) Semi-Flex Gives Interventional Radiologists New Options for Treating Cancer Tumors Using Image-Guided Radiofrequency Ablation Techniques

RITA Medical Systems Appoints Wesley E. Johnson, Jr. And Joseph M. DeVivo to Board MOUNTAIN VIEW, Calif., Aug. 19 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) today announced it has appointed senior medical industry executive Wesley E.

AngioDynamics Announces Distribution Agreement With Nipro Medical Corporation For The Aqualiner Hydrophilic Guidewire Queensbury, NY; July 31, 2003 – AngioDynamics, Inc., a wholly owned subsidiary of E-Z-EM, Inc., (AMEX: EZM) today announced that it has entered into an exclusive distribution

RITA Medical Systems Names Joseph M. DeVivo as President and Chief Executive Officer MOUNTAIN VIEW, Calif., July 29 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) today announced it has hired experienced medical industry executive Joseph M.